Vanda Pharmaceuticals
VNDA
#7962
Rank
โ‚ฌ0.32 B
Marketcap
5,44ย โ‚ฌ
Share price
0.32%
Change (1 day)
30.61%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.25 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has โ‚ฌ0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.36 B2.5%
2023-12-31โ‚ฌ0.35 B-19.3%
2022-12-31โ‚ฌ0.43 B13.88%
2021-12-31โ‚ฌ0.38 B27.83%
2020-12-31โ‚ฌ0.29 B7.3%
2019-12-31โ‚ฌ0.27 B23.85%
2018-12-31โ‚ฌ0.22 B88.22%
2017-12-31โ‚ฌ0.11 B-11.05%
2016-12-31โ‚ฌ0.13 B2.61%
2015-12-31โ‚ฌ0.13 B22.68%
2014-12-31โ‚ฌ0.10 B13.09%
2013-12-31โ‚ฌ94.38 M3.7%
2012-12-31โ‚ฌ91.02 M-20.6%
2011-12-31โ‚ฌ0.11 B-23%
2010-12-31โ‚ฌ0.14 B3.9%
2009-12-31โ‚ฌ0.14 B331.19%
2008-12-31โ‚ฌ33.23 M-43.03%
2007-12-31โ‚ฌ58.33 M141.51%
2006-12-31โ‚ฌ24.15 M-8.16%
2005-12-31โ‚ฌ26.29 M119.41%
2004-12-31โ‚ฌ11.98 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ19.26 B 7,406.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ6.09 B 2,275.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ11.42 B 4,351.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ4.61 B 1,698.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ4.98 B 1,841.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ9.15 B 3,469.68%๐Ÿ‡บ๐Ÿ‡ธ USA